AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE501.0511.65 (+2.38 %)
PREV CLOSE ( ) 489.40
OPEN PRICE ( ) 492.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 156777
TODAY'S LOW / HIGH ( )491.70 504.00
52 WK LOW / HIGH ( )389.7 838
NSE501.1011.05 (+2.25 %)
PREV CLOSE( ) 490.05
OPEN PRICE ( ) 491.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 501.10 (734)
VOLUME 2975692
TODAY'S LOW / HIGH( ) 491.00 504.00
52 WK LOW / HIGH ( )389.35 838
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
03Jan Aurobindo Pharma’s arm recalling Mirta
Aurobindo Pharma’s arm -- Aurobindo Pharma USA Inc is voluntarily recall..
03Jan Aurobindo Pharma slips as its arm reca
Aurobindo Pharma is currently trading at Rs. 460.70, down by 1.30 points..
13Dec Aurobindo Pharma’s arm recalls 59.5 th
Aurobindo Pharma’s arm -- AuroMedics Pharma LLC has initiated recall of..
12Dec Aurobindo Pharma informs about change
Aurobindo Pharma has informed that the Company has been informed by its..
29Nov IL&FS Engineering, Aurobindo Pharma an
IL&FS Engineering and Construction Company’s subsidiary -- Bangalore..
Financials
Rs. in Millions
QTR Sep 19 ANNUAL 19
Net Profit3981.315297.3
Gross Profit 5220.6 19646.2
Operating Profit 6648.525085.7
Net Sales 32216.6122578.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Pfizer (BSE)
 4165.75 (2.76%)
M.Cap (Rs. in Cr)19057.36
Alkem Laboratories (BSE)
 2351.55 (0.95%)
M.Cap (Rs. in Cr)28116.31
Aarti Drugs (BSE)
 622.85 (3.43%)
M.Cap (Rs. in Cr)1451.24
Themis Medicare (BSE)
 413.95 (5.00%)
M.Cap (Rs. in Cr)380.05
Wockhardt (BSE)
 299.05 (6.44%)
M.Cap (Rs. in Cr)3311.53
Shareholding Pattern
PROMOTERS 51.87%
NON-INSTITUTION 13.53%
MUTUAL FUNDS/UTI 12.78%
FI/BANKS/INSURANCE 0.4%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Jerina George, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.